Currently Viewing:
Supplements Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective
Overview and Diagnosis of Multiple Sclerosis
Samuel F. Hunter, MD, PhD
Economic Burden of Multiple Sclerosis and the Role of Managed Care Organizations in Multiple Sclerosis Management
Gary M. Owens, MD
Current and Emerging Treatment of Multiple Sclerosis
Felecia M. Hart, PharmD, and Jacquelyn Bainbridge, BSPharm, PharmD
Currently Reading
Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective

Cost-Effectiveness of Disease- Modifying Therapies in Multiple Sclerosis: A Managed Care Perspective

Publishing Staff
 
Senior Vice President of Operations and Clinical Affairs
Jeff D. Prescott, PharmD, RPh
Senior Clinical Projects Manager
Ida Delmendo
Clinical Projects Manager
Cindy Spielvogel
Project Manager
Jessica Toye
Proofreaders
Griselda Demassey
Maggie Shaw
Associate Editor
Jeanne Linke
Assistant Editor
Sarah Anwar
Clinical Editor
Michael R. Page, PharmD, RPh
Designer
Julianne Costello
Associate Publisher
Justin T. Gallagher
Director of Sales
Sara Belanger
National Account Managers
Gabrielle Consola
Michael Costella

Corporate
Chairman and CEO
Mike Hennessy, Sr
Vice Chairman
Jack Lepping
President
Mike Hennessy, Jr
Chief Operating Officer/CFO
Neil Glasser, CPA/CFE
President, Managed Markets, Pharmacy,and Rare Disease
Brian Haug
Executive Vice President and General Manager
John Maglione
Chief Creative Officer
Jeff Brown
Human Resources Director
Shari Lundenberg
President, Pharmacy Times Continuing Education
David Heckard

PARTICIPATING FACULTY

Faculty
Jacquelyn Bainbridge, BSPharm, PharmD
Professor
Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Department of Neurology
School of Medicine
Anschutz Medical Campus
University of Colorado
Aurora, Colorado

Felecia M. Hart, PharmD
Clinical Neurology Research Fellow
Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
University of Colorado
Aurora, Colorado

Samuel F. Hunter, MD, PhD
President
Advanced Neurosciences Institute
Franklin, Tennessee
 
University Director
NeuroNexus Center
Neurology Research at the Novel Pharmaceutics Institute
Franklin, Tennessee
 
Clinical Assistant Professor
Department of Neurology
Vanderbilt University School of Medicine
Nashville, Tennessee

Gary M. Owens, MD
President
Gary Owens Associates
Ocean View, Delaware

Editorial Support
Karen Golebowski, MS
President and Principal Biomedical Writer
Write Rite, Inc
Lopatcong, New Jersey

Cynthia L. Kryder, MS, CCC-Sp
Medical Communications Consultant
Phoenixville, Pennsylvania

Elizabeth Paczolt, MD, FACNM
Medical Consultant
Churchville, Pennsylvania

Faculty Disclosures
These faculty report relationships with the following organizations:
 
Samuel F. Hunter, MD, PhD
Consultant:
     AbbVie, Bayer, Genentech/Roche, Sanofi-Genzyme
Multicenter clinical research trial participation:
     Adamas, Biogen, Genentech/Roche, Teva
Research grant support:
     Sanofi-Genzyme
Speakers’ Bureau:
     Mallinckrodt, Novartis, Sanofi-Genzyme, Teva

Gary Owens, MD
Consultant:
     Biogen, Genentech/Roche, Genzyme, Novartis
Honoraria:
     Biogen, Genentech/Roche, Genzyme, Novartis

Jacquelyn Bainbridge, BSPharm, PharmD, and Felecia M. Hart, PharmD, have no relevant financial relationships with commercial interests to disclose.
 
Editorial Support Discloures 
Karen Golebowski, MS; Cynthia L. Kryder, MS, CCC-Sp; and Elizabeth Paczolt, MD, FACNM, have no relevant financial relationships with commercial interests to disclose.

The American Journal of Managed Care
Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.
 
Pharmacy Times Continuing Education
Planning Staff—Dave Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Donna Fausak; Nathalie Harden; and Tara DeLorenzo have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy
According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
 
Disclosure of Unapproved/Off-Label Use
The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should
note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products. The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.

PDF
 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!